Last reviewed · How we verify
Carcinoma in situ of fallopian tube
Approved treatments
- Zejula · GSK
Zejula works by blocking the action of an enzyme called PARP, which helps repair damaged DNA in cancer cells.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Carcinoma in situ of fallopian tube patent landscape — cliff calendar, originator estates, attackable patents
- Carcinoma in situ of fallopian tube treatment landscape brief
- Carcinoma in situ of fallopian tube treatment updates RSS
Frequently asked questions about Carcinoma in situ of fallopian tube
What drugs treat Carcinoma in situ of fallopian tube?
Tracked treatments include Zejula.
What is the treatment for Carcinoma in situ of fallopian tube?
Standard treatment for Carcinoma in situ of fallopian tube includes Zejula. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Carcinoma in situ of fallopian tube patent cliff · Carcinoma in situ of fallopian tube CI report
- Treatment: Zejula · GSK
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing